In contrast, in a more recent assessment of 32 studies the authors concluded that aspirin use was not associated with risk of breast cancer, although a statistically significant reduction in the risk of hormone receptor (HR)-positive subtypes was noted [5]. The gene discussed is NR4A1; the disease is breast cancer.